Literature DB >> 30363479

Huntington's Disease: Prevalence and Psychological Indicators of Pain.

Mandy Underwood1, Sheila Bonas1, Maria Dale1,2.   

Abstract

BACKGROUND: Huntington's disease (HD) is a genetic neurodegenerative condition that involves impairments in movement, cognition, and mood. Research is lacking in HD with regard to the prevalence of pain and the relationships between psychological factors and pain. The aim of this research was to investigate the prevalence of pain and identify the psychological factors associated with pain severity in people with HD.
METHODS: This data-mining study used data from 1474 people who participated in the European Huntington's Disease Network (EHDN) REGISTRY study. Pain severity was measured using the Medical Outcome Study 36-item short-form health survey. Separate ordinal regression analyses were conducted with participant-rated and interviewer-rated psychological measures (the Hospital Anxiety and Depression Scale-Snaith Irritability Scale and the Unified Huntington's Disease Rating Scale). The psychological factors considered were anxiety, depression, irritability, aggression, low self-esteem, and apathy.
RESULTS: The prevalence of pain in the total sample was 41% (stage I, 42%; stage II, 44%; stage III, 39%; stages IV and V, 50%). After controlling for confounding variables, pain severity was significantly associated with participant-rated anxiety and depression. Interviewer-rated anxiety, depression, and irritability also were significantly associated with severity of pain after controlling for confounding variables.
CONCLUSIONS: This research confirmed that pain is indeed an issue for people with HD, particularly during the later stages of the disease. Caregivers and health professionals should consider the possibility that people with HD might be experiencing pain, particularly if they are showing signs of anxiety, depression, or irritability.

Entities:  

Keywords:  Huntington's disease; anxiety; depression; irritability; pain

Year:  2016        PMID: 30363479      PMCID: PMC6174505          DOI: 10.1002/mdc3.12376

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  36 in total

1.  Huntington disease: clinical care and evaluation.

Authors:  I Shoulson; S Fahn
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

2.  Expanding Melzack's pain neuromatrix. The Threat Matrix: a super-system for managing polymodal threats.

Authors:  Eric J Visser; Stephanie Davies
Journal:  Pain Pract       Date:  2010 Mar-Apr       Impact factor: 3.183

3.  Huntington's disease.

Authors:  Erik Scherder; Monique Statema
Journal:  Lancet       Date:  2010-10-30       Impact factor: 79.321

Review 4.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

5.  Human aggression.

Authors:  Craig A Anderson; Brad J Bushman
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

6.  Behavioral changes in Huntington Disease.

Authors:  D Craufurd; J C Thompson; J S Snowden
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Oct-Dec

7.  Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.

Authors:  Jennifer C Thompson; Jenny Harris; Andrea C Sollom; Cheryl L Stopford; Elizabeth Howard; Julie S Snowden; David Craufurd
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

Review 8.  An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.

Authors:  Kanwaljit Chopra; Vipin Arora
Journal:  Expert Opin Ther Targets       Date:  2013-12-03       Impact factor: 6.902

Review 9.  Comorbidity of pain and anxiety disorders.

Authors:  Oye Gureje
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

Review 10.  Psychopathology in verified Huntington's disease gene carriers.

Authors:  E van Duijn; E M Kingma; R C van der Mast
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

View more
  5 in total

Review 1.  Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Authors:  Xiaoling Li; Guanghui Cao; Xiaokang Liu; Tie-Shan Tang; Caixia Guo; Hongmei Liu
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

2.  Lower Prevalence of Chronic Pain in Manifest Huntington's Disease: A Pilot Observational Study.

Authors:  Marianna Delussi; Vittorio Sciruicchio; Paolo Taurisano; Francesca Morgante; Elena Salvatore; Isabella Pia Ferrara; Livio Clemente; Chiara Sorbera; Marina de Tommaso
Journal:  Brain Sci       Date:  2022-05-21

Review 3.  Glutamatergic fast-spiking parvalbumin neurons in the lateral hypothalamus: Electrophysiological properties to behavior.

Authors:  Justin N Siemian; Sarah Sarsfield; Yeka Aponte
Journal:  Physiol Behav       Date:  2020-04-11

4.  Disease Burden of Huntington's Disease (HD) on People Living with HD and Care Partners in Canada.

Authors:  Eileen Shaw; Michelle Mayer; Paul Ekwaru; Suzanne McMullen; Erin Graves; Jennifer W Wu; Nathalie Budd; Bridget Maturi; Tara Cowling; Tiago A Mestre
Journal:  J Huntingtons Dis       Date:  2022

5.  Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated.

Authors:  Xue Bai; Gerard Batallé; Gianfranco Balboni; Olga Pol
Journal:  Antioxidants (Basel)       Date:  2022-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.